title: [A case of advanced hepatocellular carcinoma responding to suppository of Tegafur].
abstract: We report a case of advanced hepatocellular carcinoma (HCC) successfully controlled by the suppository administration of Tegafur alone. Five months after initiation of the drug, excellent reduction of tumors and decrease of serum alpha-feto-protein (AFP) level were seen without any side effects. Also, twenty-four months after of the treatment, no regrowth of tumors or increase in the serum AFP level was seen. Because Tegafur is a time-dependent agent, advanced HCC may be controlled by continuous administration for a long period.
authors.affiliation: Dept. of Radiology, Saishunsou Hospital.
authors.forename: K
authors.initials: K
authors.lastname: Kudo
authors.forename: A
authors.initials: A
authors.lastname: Arakawa
authors.forename: Y
authors.initials: Y
authors.lastname: Takagi
authors.forename: R
authors.initials: R
authors.lastname: Nishimura
authors.forename: Y
authors.initials: Y
authors.lastname: Yamashita
authors.forename: M
authors.initials: M
authors.lastname: Takahashi
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D006528:Carcinoma, Hepatocellular / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D008113:Liver Neoplasms / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013488:Suppositories; D005641:Tegafur / Q000008:administration & dosage*; D000509:alpha-Fetoproteins / Q000032:analysis
chemical_list: D000964:Antimetabolites, Antineoplastic; D013488:Suppositories; D000509:alpha-Fetoproteins; D005641:Tegafur